Jefferies, TD Cowen, BMO Capital, RBC Capital and Wells Fargo acted as joint book running managers for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MORF:
- Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering
- Morphic Therapeutic Announces Proposed Public Offering
- Morphic announces common stock offering, no amount given
- Morphic price target raised to $106 from $83 at BMO Capital
- Morphic price target raised to $80 from $75 at RBC Capital
